ANTARA (MICRONIZED) Drug Patent Profile
✉ Email this page to a colleague
When do Antara (micronized) patents expire, and when can generic versions of Antara (micronized) launch?
Antara (micronized) is a drug marketed by Lupin and is included in one NDA. There are two patents protecting this drug and one Paragraph IV challenge.
This drug has two patent family members in two countries.
The generic ingredient in ANTARA (MICRONIZED) is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-four suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Antara (micronized)
A generic version of ANTARA (MICRONIZED) was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANTARA (MICRONIZED)?
- What are the global sales for ANTARA (MICRONIZED)?
- What is Average Wholesale Price for ANTARA (MICRONIZED)?
Summary for ANTARA (MICRONIZED)
International Patents: | 2 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 138 |
Patent Applications: | 4,099 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for ANTARA (MICRONIZED) |
DailyMed Link: | ANTARA (MICRONIZED) at DailyMed |
Paragraph IV (Patent) Challenges for ANTARA (MICRONIZED)
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
ANTARA (MICRONIZED) | Capsules | fenofibrate | 43 mg and 130 mg | 021695 | 1 | 2008-09-15 |
US Patents and Regulatory Information for ANTARA (MICRONIZED)
ANTARA (MICRONIZED) is protected by four US patents.
Patents protecting ANTARA (MICRONIZED)
Treating metabolic syndrome with fenofibrate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING SEVERE HYPERTRIGLYCERIDEMIA
Treating metabolic syndrome with fenofibrate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
Reduced dose pharmaceutical compositions of fenofibrate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING PRIMARY HYPERCHOLESTEROLEMIA AND MIXED DYSLIPIDEMIA
Reduced dose pharmaceutical compositions of fenofibrate
Patent Number: ⤷ Sign Up
Patent Expiration: ⤷ Sign Up
Patented Use: TREATING SEVERE HYPERTRIGLYCERIDEMIA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-004 | Oct 18, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-002 | Nov 30, 2004 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-001 | Nov 30, 2004 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-005 | Oct 18, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-005 | Oct 18, 2013 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-003 | Nov 30, 2004 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ANTARA (MICRONIZED)
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-001 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-002 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-002 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-003 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-003 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
Lupin | ANTARA (MICRONIZED) | fenofibrate | CAPSULE;ORAL | 021695-003 | Nov 30, 2004 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ANTARA (MICRONIZED)
See the table below for patents covering ANTARA (MICRONIZED) around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ukraine | 72925 | ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО МІСТИТЬ ФЕНОФІБРАТ, І СПОСІБ ЇЇ ОДЕРЖАННЯ (ВАРІАНТИ);ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, СОДЕРЖАЩАЯ ФЕНОФИБРАТ, И СПОСОБ ЕЕ ПОЛУЧЕНИЯ (ВАРИАНТЫ) (FENOFIBRATE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARATION (VARIANTS)) | ⤷ Sign Up |
Spain | 2324670 | ⤷ Sign Up | |
South Africa | 200200169 | Pharmaceutical composition containing fenofibrate and method for the preparation thereof. | ⤷ Sign Up |
Turkey | 200200008 | ⤷ Sign Up | |
China | 1682707 | Pharmaceutical composition comprising fenofibrate and process for its preparation | ⤷ Sign Up |
Denmark | 1194140 | ⤷ Sign Up | |
>Country | >Patent Number | >Title | >Estimated Expiration |